HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Gasbarrini Selected Research

Lactose Intolerance (Intolerance, Lactose)

12/2016Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
1/2016Digestive Enzyme Supplementation in Gastrointestinal Diseases.
1/2015Lactose intolerance genetic testing: is it useful as routine screening? Results on 1426 south-central Italy patients.
6/2008Quick test: a new test for the diagnosis of duodenal hypolactasia.
1/2008Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet.
1/2008Adverse reactions to food: allergies and intolerances.
1/2006Management and treatment of lactose malabsorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Gasbarrini Research Topics

Disease

58Neoplasms (Cancer)
09/2022 - 07/2004
48Hepatocellular Carcinoma (Hepatoma)
09/2022 - 07/2009
45Infections
09/2022 - 04/2002
43Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022 - 01/2003
34Inflammation (Inflammations)
06/2022 - 09/2004
24COVID-19
04/2022 - 01/2020
24Ulcerative Colitis
01/2022 - 04/2005
24Fibrosis (Cirrhosis)
01/2022 - 01/2012
24Liver Diseases (Liver Disease)
12/2021 - 09/2010
22Clostridium Infections
12/2021 - 01/2014
18Crohn Disease (Crohn's Disease)
06/2021 - 04/2005
14Liver Cirrhosis (Hepatic Cirrhosis)
11/2021 - 06/2010
14Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
06/2021 - 01/2015
11Diarrhea
06/2022 - 01/2003
11Dysbiosis
01/2022 - 08/2013
11Thrombosis (Thrombus)
01/2022 - 01/2008
10Colitis
01/2022 - 12/2011
9Hypersensitivity (Allergy)
06/2022 - 01/2017
9Celiac Disease (Celiac Sprue)
03/2019 - 03/2003
8Liver Neoplasms (Liver Cancer)
08/2021 - 03/2013
8Hepatitis C
03/2017 - 04/2003
7Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2022 - 06/2009
7Non-alcoholic Fatty Liver Disease
06/2021 - 03/2014
7Disease Progression
01/2021 - 04/2003
7Necrosis
10/2020 - 04/2016
7Lactose Intolerance (Intolerance, Lactose)
12/2016 - 01/2006
6Chronic Hepatitis C
05/2021 - 09/2012
6Alcoholism (Alcohol Abuse)
11/2020 - 05/2009
5Pancreatitis
11/2021 - 07/2014
5Venous Thrombosis (Deep-Vein Thrombosis)
10/2021 - 09/2013
5Obesity
07/2021 - 10/2010
5Atherosclerosis
01/2021 - 07/2002
5Hemorrhage
12/2020 - 12/2009
4Food Hypersensitivity (Food Allergy)
06/2022 - 01/2008
4Dyspepsia (Indigestion)
03/2022 - 04/2002
4Carcinogenesis
03/2022 - 07/2009
4Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 12/2010
4Asthma (Bronchial Asthma)
03/2022 - 01/2021
4Malnutrition (Nutritional Deficiencies)
11/2021 - 07/2014
4Stomach Neoplasms (Stomach Cancer)
03/2021 - 07/2004
4Constipation
01/2021 - 03/2015
4Sarcopenia
01/2021 - 01/2018
4End Stage Liver Disease
10/2018 - 01/2011
4Hepatic Encephalopathy
11/2016 - 06/2003

Drug/Important Bio-Agent (IBA)

24Anti-Bacterial Agents (Antibiotics)IBA
07/2021 - 11/2004
23Sorafenib (BAY 43-9006)FDA Link
09/2022 - 07/2009
20Pharmaceutical PreparationsIBA
03/2022 - 05/2009
17Antiviral Agents (Antivirals)IBA
06/2022 - 01/2012
16Biomarkers (Surrogate Marker)IBA
09/2022 - 06/2010
14Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2005
13Infliximab (Remicade)FDA Link
06/2021 - 02/2006
11AntibodiesIBA
04/2017 - 05/2002
10Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2004
9Biological ProductsIBA
04/2022 - 07/2006
9alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 07/2014
8Urea (Carbamide)FDA LinkGeneric
04/2022 - 04/2002
8Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2022 - 01/2007
8AntigensIBA
11/2021 - 07/2002
8PrebioticsIBA
07/2021 - 10/2010
8Ribavirin (Virazole)FDA LinkGeneric
10/2018 - 01/2012
8Rifaximin (L 105)FDA Link
01/2018 - 06/2009
7AnticoagulantsIBA
10/2021 - 12/2009
6Bile Acids and Salts (Bile Acids)IBA
06/2022 - 06/2003
6CytokinesIBA
01/2022 - 01/2011
5LipidsIBA
06/2022 - 05/2012
5InterleukinsIBA
02/2022 - 01/2020
5Glucose (Dextrose)FDA LinkGeneric
11/2021 - 06/2010
5Dextrans (Dextran)FDA Link
11/2021 - 12/2011
5SodiumIBA
10/2021 - 12/2011
5NickelIBA
08/2021 - 01/2017
5Proton Pump InhibitorsIBA
01/2021 - 07/2010
5AlbuminsIBA
01/2021 - 03/2013
5Glutens (Glutelin)IBA
10/2019 - 10/2005
5InterferonsIBA
03/2017 - 04/2003
4C-Reactive ProteinIBA
04/2022 - 01/2020
4Oxygen (Dioxygen)IBA
03/2022 - 04/2003
4Interleukin-6 (Interleukin 6)IBA
02/2022 - 01/2020
4Monoclonal AntibodiesIBA
01/2022 - 02/2009
4vedolizumabIBA
01/2022 - 11/2019
4Tyrosine Kinase InhibitorsIBA
08/2021 - 01/2017
4LipopolysaccharidesIBA
06/2021 - 12/2018
4Therapeutic UsesIBA
05/2020 - 02/2006
4Alkaline PhosphataseIBA
01/2020 - 07/2014
4ARQ 197IBA
02/2017 - 01/2013
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2017 - 01/2003
4LactaseIBA
01/2016 - 01/2005
4N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
10/2014 - 09/2012
3SirtuinsIBA
09/2022 - 12/2021
3NitrogenIBA
04/2022 - 06/2003

Therapy/Procedure

107Therapeutics
09/2022 - 04/2003
23Liver Transplantation
01/2022 - 06/2003
20Fecal Microbiota Transplantation
12/2021 - 09/2014
17Transplantation
07/2021 - 09/2010
12Drug Therapy (Chemotherapy)
03/2022 - 11/2004
7Biological Therapy
02/2021 - 07/2006
7Nutritional Support (Artificial Feeding)
01/2021 - 01/2009
6Radiofrequency Ablation
01/2022 - 03/2015
6Gluten-Free Diet
11/2021 - 03/2003
5Length of Stay
10/2020 - 01/2019
4Aftercare (After-Treatment)
01/2022 - 07/2009